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Abstract:  Many  natural  products  with  biologically  interesting  structures  have  been 
isolated from marine animals and plants such as sponges, corals, worms, etc. Some of them 
are discorhabdin alkaloids. The discorhabdin alkaloids (discorhabdin A-X), isolated from 
marine  sponges,  have  a  unique  structure  with  azacarbocyclic  spirocyclohexanone  and 
pyrroloiminoquinone units. Due to their prominent potent antitumor activity, discorhabdins 
have  attracted  considerable  attention.  Many  studies  have  been  reported  toward  the 
synthesis of discorhabdins. We have accomplished the first total synthesis of discorhabdin 
A (1), having the strongest activity in vitro among discorhabdins in 2003. In 2009, we have 
also  accomplished  the  first  total  synthesis  of  prianosin  B  (2),  having  the  16,17-
dehydropyrroloiminoquinone moiety, by a novel dehydrogenation reaction with a catalytic 
amount of NaN3. These synthetic studies, as well as syntheses of the discorhabdins by 
various chemists to-date, are reviewed here.  
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1. Introduction  
Marine  organisms  contain  various  elements  that  are  important  for  their  survival  and  for  their 
relationships with other living bodies. The nature, action and role of many of these elements have not 
yet been elucidated. Many marine organic compounds have been shown to be also useful for humans; 
as drugs, agricultural medicines, cosmetics and health foods [1–5]. In particular, a number of marine 
drugs  have  been  developed  in  recent  years.  Marine  natural  products  offer  challenging  targets  to 
synthetic  chemists  due  to  their complicated  structures  that  exhibit  remarkable biological activities  
[6–11].  However,  the  chemical  synthesis  of  marine  drugs  is  of  upmost  importance as  a  synthetic 
supply is needed when it is difficult to maintain the amount of the natural source.  
Figure 1. The structure of discorhabdin alkaloids. 
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In the past several years, many new pyrroloiminoquinone alkaloids have been isolated from marine 
sources. The pyrroloiminoquinone alkaloid family consists of discorhabdins [12–16], prianosins [17], 
makaluvamines [18–21], batzellins [22–23], wakayins [24] and damirones [25–26], and have potent 
antitumor  activities  derived  from  their  unique  fused  ring  structures  [27].  Among  them,  the 
discorhabdin alkaloids were isolated from marine sponges such as New Zealand sponges of the genus 
Latrunculia,  the  Okinawan  sponge  Prianos  melanos,  the  Fijian  sponge  Zyzzya  cf.  Marsailis,  etc.  
[12–16].  All  of  them  have  unique  structures,  with  azacarbocyclic  spirocyclohexanone  and 
pyrroloiminoquinone structures. Figure 1 shows some representative discorhabdin alkaloids. Among 
the various isolated discorhabdins (A–X), discorhabdins A (1) [28,29], B (4) [28,29], D (3) [30], H 
[15], I [14], J [12], L [14], M [12], N [12], Q (5) [31], R [32], X (6) [33], and prianosins B (2), D [34] Mar. Drugs 2010, 8                            
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have a sulfur-containing fused ring structure. Discorhabdins S (11), T (12) and U (13) [13] have a 
methyl sulfide moiety. Discorhabdin W (14) [35] is a dimeric structure with a disulfide bond, while the 
others have no sulfur atom. Furthermore, discorhabdins F (9) [36], Q, S, T and prianosin B (2) contain 
a 16,17-dehydropyrroloiminoquinone moiety. Because of their prominent potent antitumor activity and 
unusual  ring  structure,  pyrroloiminoquinone  alkaloid  synthesis  has  attracted  the  interest  of  many 
organic chemists, and over the last decade, the total synthesis of a few of them as well as synthetic 
approaches has appeared. Our group accomplished the first total syntheses of discorhabdin C (7) [37], 
makaluvamine F [38,39] and discorhabdin A (1) [40–43]. In 2009, we also accomplished the first total 
synthesis of prianosin B (2) [44]. In this review, we describe the total syntheses of the discorhabdins 
by various chemists to-date. 
2. Studies of the Total Synthesis of Discorhabdin C 
In 1986, discorhabdin C (7) was isolated from the sponge Latrunculia in New Zealand by Munro  
et al. and was found to exhibit a strong cytotoxicity against tumor cells (ED50 = 30 ng/mL against 
P388 and <100 ng/mL against L1210) [45]. Discorhabdin C was the first isolated of the discorhabdins 
and much attention has been paid to the total synthesis of this attractive target.  
2.1. Our Synthesis [37] 
The problems in the synthesis of discorhabdin C are the construction of highly fused ring systems 
and the formation of the indoloquinone imine moiety. An overview of our approaches to the synthesis 
of discorhabdin C is illustrated in Scheme 1. One approach involves the imine formation between the 
tryptamine amine of the side chain and the indoloquinone carbonyl as the final step of the synthesis 
(route  a).  Another  approach  involves  the  oxidative  coupling  of  the  indoloquinone  imine  by 
phenyliodine bistrifluoroacetate (PIFA) as the final step (route b) [46]. 
Scheme 1. Retrosynthetic analysis for discorhabdin C. 
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A  reasonable  starting  material  for  route  a  is  2-hydroxy-4-methoxybenzaldehyde  (17).  The 
benzylation  of  17  with  BnBr  and  K2CO3  followed  by  condensation  with  ethyl  azidoacetate 
(N3CH2CO2Et) in ethanolic sodium ethoxide gave the vinyl azide, which was decomposed in boiling 
xylene to give the 2-(ethoxycarbonyl)indole (18) in 73% yield over three steps. Hydrolysis of the ester 
group of 18 with KOH gave indolecarboxylic acid, which was decarboxylated with copper chromite 
under thermal conditions to give the 4,6-disubstituted indole (19). The treatment of the indole 19 with 
dimethyl(methylene)ammonium iodide (CH2=N
+Me2I
-) gave the 3-(dimethylamino)methyl derivative. 
The dimethylamino group was replaced by a cyano group using NaCN via the quaternary salt to yield Mar. Drugs 2010, 8                            
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the 3-(cyanomethyl)indole (20). Catalytic hydrogenation of the cyano group of 20 with Raney Ni 
followed  by  protection  of  the  resulting  amino  group  with  the  trifluoroacetyl  or  the 
[(trimethylsilyl)ethoxy]carbonyl  (Teoc)  groups  afforded  21a  (R  =  COCF3)  and  21b  (R  =  Teoc), 
respectively. Debenzylation of 21a,b with reduction followed by oxidation using Fremy’s salt gave the 
corresponding  quinones  (22a,b).  The  treatment  of  22a,b  with  3,5-debromotyramine  hydrobromide 
gave  the  phenol  derivatives  (23a,b).  Silylation  of  23a,b  with  o-silylated  ketene  acetal 
(MeCH=C(OMe)(OSiMe3))  followed  by  oxidation  with  PIFA  resulted  in  the  desired  intermediate 
(15a,b). Unfortunately, all attempts to effect the final imine formation between the tryptamine nitrogen 
and the indoloquinone carbonyl in these types of intermediates failed (Scheme 2). 
Scheme 2. The synthetic approach toward discorhabdin C via route a. 
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An  alternative  approach  (route  b),  in  which  phenolic  coupling  of  the  previously  produced 
aminoindoloquinone imine (16) is employed in the final step, accomplished the first total synthesis of 
discorhabdin C (7). The direct imine formation from the indoloquinone was achieved by protection of 
the indoloquinone nitrogen with the tosyl group followed by an acidic dehydrative treatment. The 
treatment of 22b with p-toluenesulfonyl chloride gave the N-tosylate (24). Deprotection of the Teoc 
group of 24 with anhydrous p-toluenesulfonic acid in acetonitrile in the presence of 3Å molecular 
sieves and sodium bicarbonate yielded an unstable indoloquinone imine (25), which was subjected to Mar. Drugs 2010, 8                            
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the  following  one-pot  transformation  without  further  purification.  When  treated  with  
3,5-dibromotyramine  hydrobromide  in  ethanol,  the  indoloquinone  imine  underwent  a  facile 
substitution reaction and subsequent detosylation to give the phenolic aminoindoloquinone imine (16). 
The conversion of 16 into its corresponding silylether and the subsequent oxidative coupling reaction 
using PIFA gave rise to discorhabdin C (7) (Scheme 3). 
This efficient route was used for the synthesis of a wide variety of previously inaccessible sulfur-
containing discorhabdin and prianosin alkaloids (vide infra).  
Scheme 3. The total synthesis of discorhabdin C via route b. 
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2.2. Yamamura’s Synthesis [47,48] 
At the same time as our report, Yamamura et al. also reported the total synthesis of discorhabdin C 
(7). Their synthesis was initiated from the conversion of the known nitrobenzaldehyde (26) into the 
corresponding amide compound (27) in a two-step procedure: reduction of the nitro group followed by 
Z protection of the generated amine. Manipulation of 27 involving the Curtius reaction provided the 
diaminobenzene, whose two amino functions could be differentiated by the diverse protection groups 
(Teoc and Z). Thus, after reductive removal of the benzyloxycarbonyl group, the generated amine was 
benzylated  in  the  usual  manner  to  give  29.  Among  a  variety  of  methods  for  indole-skeleton 
constructions, they chose the reaction of 29 with ethyl 4-chloroacetoacetate, which gave rise to the 
simultaneous  introduction  of  a  C2  unit  at  the  C-3  position  of  the  indole  (30).  Access  to  the 
tetrahydropyrroloquinoline (32) was effected by Gannortt's procedure, i.e., the stepwise removal of the 
amino and carboxylic acid protective groups of 30 followed by lactam formation provided the tricyclic 
product (31) in a good overall yield. The amide function of 31 was reduced with BH3· SMe2, and the 
resulting  amine  was  oxidized  with  CAN  (ceric  ammonium  nitrate)  to  produce  the  expected 
tetrahydropyrroloquinoline  (32)  in  two  steps,  which  further  underwent  a  nucleophilic  substitution 
reaction with 3,5-dibromotyramine to furnish 33 in 78% yield. The electrolysis of bromophenol (33) 
furnished the expected benzyldiscorhabdin C (34) accompanied by the ring-expanded product (35) 
(Scheme 4).  Mar. Drugs 2010, 8                            
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Scheme 4. The synthesis of benzyldiscorhabdin C by Yamamura et al. 
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Unfortunately, in the last step, all efforts made to remove the benzyl protective group of 34 were 
unsuccessful.  Therefore,  they  synthesized  the  bromophenol  derivative  (16).  The  indole  (30)  was 
hydrogenated  under  acidic  conditions  to  remove  the  benzyl  and  Teoc  protective  groups,  and  the 
succeeding lactamization as in the case of 30 yielded 36. The conversion of 36 into 16 smoothly 
proceeded according to the procedure for the synthesis of 33. Upon anodic oxidation, 16 produced the 
desired discorhabdin C (7) in 24% yield accompanied by the ring-expanded product (37) in 6% yield 
(Scheme 5). 
Scheme 5. The total synthesis of discorhabdin C by Yamamura et al. 
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2.3. Heathcock’s Synthesis [49] 
In 1999, Heathcock et al. accomplished the total synthesis of discorhabdin C (7) by a phenolic 
coupling reaction with cupric chloride. 2-Nitroguaiacol (38) was chosen as the starting material. The 
benzylation of the phenolic hydroxyl group and reduction of the nitro group with Fe and HCl gave the 
corresponding amino compound, which underwent regioselective iodination with ICl to provide the 
ortho-iodo derivative 39. The Heck reaction of 39 with Pd(OAc)2 and (o-tol)3P yielded an indole (40), 
which  was  followed  by  reduction  with  LiAlH4,  and  protection  with  Boc  and  Ts  to  provide  the  
7-benzyloxy-1-tosyl  compound  (41).  The  debenzylation  of  41  with  H2  and  Pd/C  afforded  the  
7-hydroxyindole  (42),  of  which  treatment  with  Fremy's  salt  gave  the  para-quinone  (43).  The 
deprotection  of  43  with  TFA  (CF3CO2H)  produced  the  indoloquinoneimine  (25).  The  imine  (25) 
underwent a nucleophilic substitution reaction with 3,5-dibromotyramine to furnish 44. The treatment 
of  44  with  three  equivalents  of  CuCl2  and  four  equivalents  of  Et3N  under  O2  bubbling  gave  
N-tosyldiscorhabdin C (45), of which the detosylation with NaOMe resulted in the formation of the 
expected discorhabdin C (7) (Scheme 6).  
Scheme 6. The total synthesis of discorhabdin C by Heathcock et al. 
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Heathcock et al. also achieved the total synthesis of (± )-discorhabdin E (8) [49]. The imine (25) 
underwent a nucleophilic substitution reaction with o-bromotyramine to furnish 46. The treatment of 
46  with  three  equivalents  of  CuCl2  and  four  equivalents  of  Et3N  under  O2  bubbling  gave  Mar. Drugs 2010, 8                            
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N-tosyldiscorhabdin E (47), the detosylation of which with NaOMe resulted in the formation of the 
expected (± )-discorhabdin E (8). 
Scheme 7. The total synthesis of (± )-discorhabdin E by Heathcock et al. 
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3. Studies of the Total Synthesis of Sulfur-Containing Makaluvamine, Makaluvamine F (48) [38,39] 
Among the makaluvamines, makaluvamine F (48) has the most potent biological activities (e.g., 
cytotoxicity towards the human colon tumor cell line HCT-116 (IC50 = 0.17 M) and inhibition of 
topoisomerase II). Makaluvamine F (48) has an -aminodihydrobenzothiophene skeleton, which is a 
labile  N,S-acetal  structure  present  in  all  sulfur-containing  discorhabdins.  Synthetic  studies  of  the 
makaluvamines and discorhabdins have been carried out by several groups. However, in most cases, 
these  efforts  have  been  devoted  only  to  the  diverse  preparations  of  the  pyrroloiminoquinone  and 
spirodienone  units.  To  the  best  of  our  knowledge,  the  total  syntheses  of  the  sulfur-containing 
discorhabdins and makaluvamine F had not been reported until our synthesis, despite their potent 
cytotoxicity and their unique structure. This is probably due to the difficulty in construction of the 
labile and highly strained N,S-acetal skeletons. In our efforts to synthesize the discorhabdin alkaloids, 
we succeeded in the total synthesis of discorhabdin C (7) using the PIFA-mediated spirocyclization 
reaction. Thus, the remaining challenge for the total syntheses of these targets (the sulfur-containing 
family)  was  the  construction  of  the  labile  and  highly  strained  N,S-acetal  skeletons.  Our  synthetic 
strategy for the total synthesis of makaluvamine F (48) is shown in Scheme 8. 
Scheme 8. Retrosynthetic analysis of makaluvamine F (48). 
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3.1. Facile and Direct Synthesis of the Pyrroloiminoquinone Unit [50]  
We found that the treatment of phenyl ethers with an alkylazido group (49) in the presence of PIFA-
TMSOTf  in  (CF3)2CHOH-ROH  or  CF3CH2OH-ROH  gave  the  corresponding  quinone  imine 
dimethylacetals (50), which in (CF3)3CHOH-H2O or CF3CH2OH-H2O gave the corresponding quinine 
imines (51) [51] (Scheme 9). Quinone imines and quinone imine monoacetals have been proposed as 
the intermediates in a number of biological processes. Quinone imines were also found in the structure 
of marine alkaloids. 
Scheme 9. Intramolecular cyclization of phenylethers bearing an alkylazido group. 
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We  have  developed  a  facile  and  direct  preparation  of  the  quinone  imine  derivatives,  and  very 
recently reported the synthesis of pyrroloiminoquinones from the indole bearing an alkylazido group 
[52]. The starting substrate was prepared as follows. The treatment of 6,7-dimethoxyindole (52) with 
oxalyl chloride followed by LAH reduction gave 3-(hydroxyethyl)indole (53) (95% yield), which was 
converted to  3-(azidoethyl)indole  (55) via  3-(iodoethyl)indole  (54) in 65% yield.  The N-protected  
3-(azidoethyl)indoles  (56a-f)  were  readily  prepared  from  55  by  standard  alkylation  and  acylation 
methods. First, we examined the reaction of 55 with PIFA-TMSOTf, but only a complex mixture was 
obtained. The reactions of 56a (R = Me) and 56b (R = Si(i-Pr)3) with PIFA-Me3SiOTf also gave 
complex mixtures, probably due to the side reactions occurring at the 1- or 3-position on the indole 
nucleus. In fact, several groups have already reported that a 1-, 2- or 3-substituted indole derivative is 
obtained  from  the  reaction  of  indoles  with  iodobenzene  diacetate.  Therefore,  we  examined  the 
reactions of the 1-protected indoles (56c-f) with PIFA-Me3SiOTf in the presence of H2O. We found 
that  the  corresponding  N-deprotected  pyrroloiminoquinones  (57)  or  the  N-protected 
pyrroloiminoquinones (25 and 58) were obtained in moderate yields when the indoles protected with 
an electron-withdrawing group, such as the acetyl, benzoyl, tosyl or benzyloxycarbonyl group, were 
treated with PIFA-Me3SiOTf in (CF3)2CHOH-H2O (50:1) (Scheme 10).  Mar. Drugs 2010, 8                            
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Scheme 10. A novel synthetic method for pyrroloiminoquinones. 
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3.2. Synthesis of the Dihydrothiophene Units [52,53]  
In our previous studies, we developed the direct sulfenylation of phenyl ethers using PIFA [54,55]. 
Furthermore, we developed the intramolecular cyclization of phenyl ethers (59) bearing an alkylsulfide 
group  using  PIFA  in  (CF3)2CHOH  and  PIFA-BF3· Et2O  in  CH2Cl2  that  specifically  produced  the 
corresponding sulfur-containing heterocycles (60) (Scheme 11) [52].  
Scheme 11. Intramolecular cyclization of phenylethers bearing an alkyl sulfide group. 
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A plausible reaction mechanism is that the electron-rich aromatic ring is initially oxidized by the 
activated PIFA via a single electron transfer (SET), and then the sidechain attacks the radical cation. 
Although  other  mechanisms,  such  as  the  one  via  the  sulfonium  salt  could  also  be  possible,  we 
proposed the mechanism via the radical cation (Scheme 12). Mar. Drugs 2010, 8                            
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Scheme 12. A plausible mechanism for the cyclization reaction of 59. 
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We constructed the dihydrobenzothiophenes using the direct sulfenylation of phenol ethers with 
PIFA  and  arylthiols.  The  synthesis  was  initiated  from  the  methyl  4-hydroxyphenylacetate  (61)  to 
afford the phenol ether (63) bearing an alkyl sulfide side chain in five steps. The treatment of the 
phenol ether (63) with PIFA-BF3· Et2O followed by the treatment of aqueous MeNH2 provided the 
dihydrobenzothiophenes (64) (Scheme 13). 
Scheme 13. Synthesis of dihydrobenzothiophene. 
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Next, we attempted to synthesize the -azidodihydrobenzothiophenes, which can serve as an N,S-
acetal equivalent, by the introduction of an azido group to the dihydrobenzothiophene derivatives. 
After considerable effort, we found a novel and direct -azidation method for cyclic sulfides using a 
combination of PhI=O and Me3SiN3 (Scheme 14) [53]. A plausible reaction mechanism is proposed in 
Scheme 15. The sulfonium cation (66) initially formed by the reaction of the sulfide with PhI=O-
Me3SiN3, whose combination was studied by Magnus and co-workers, is then deprotonated to give a 
cation intermediate (67). The azido anion attacks the -position of 67 to produce the -azido sulfide (65). 
Scheme 14. Synthesis of -azidodihydrobenzothiophene derivatives. 
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Scheme  15.  A plausible reaction mechanism for -azidation of dihydrobenzothiophene 
derivatives. 
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Although azidation of 5-bromo-6-benzyloxydihydrobenzothiophene (70) gave only a trace amount 
of  the  expected  -azido  compound,  treatment  of  the  acetylated  compound  (71)  with  PhI=O  and 
Me3SiN3 followed by hydrolytic deprotection of the 6-acetoxy group provided the 2-azido-5-bromo-6-
hydroxydihydrobenzothiophene (72) (Scheme 16). 
Scheme 16. The synthesis of 2-azido-5-bromo-6-hydroxydihydrobenzothiophene (72). 
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3.3. Total Synthesis of (-Makaluvamine F (48) [38,39] 
Catalytic hydrogenation of 72 followed by the coupling reaction with 57 in MeOH in the presence 
of  Me3SiOTf  gave  makaluvamine  F  only  in  a  poor  yield.  Finally,  we  found  that  the  catalytic 
hydrogenation of 72 using 10% Pd-C in the presence of four equivalents of trifluoroacetic acid (TFA) 
resulted in complete reduction leading to a TFA salt in quantitative yield without any side reactions. 
The  final  coupling  reaction  in  MeOH  between  both  synthetic  precursors,  the  TFA  salt  and  57, 
proceeded to give the TFA salt of makaluvamine F (48) (Scheme 17).  
Scheme 17. The total synthesis of (± )-makaluvamine F (48). 
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4. Total Synthesis of Discorhabdin A [40–43] 
In 1987, prianosin A [28] was isolated from the Okinawan sponge Prianos melanos by Kobayashi 
et  al.,  and  in  1988,  discorhabdin  A  [29]  was  isolated  from  New  Zealand  sponges  of  the  genus 
Latrunculia by Munro et al. Some years later, it was found that prianosin A and discorhabdin A were 
the same compound. Discorhabdin A (prianosin A) is antimicrobial and has a strong cytotoxicity (IC50 
values of 37 ng/mL, 14 ng/mL, 40 ng/mL and 13 ng/mL against L1210, L5178Y, P388 and xrs-6 in 
vitro,  respectively,  and  ED50  values  of  50  ng/mL  against  P388).  Our  next  synthetic  target  was 
discorhabdin  A  (1),  which  has  a  unique  sulfur-containing  fused  ring  system  incorporating 
azacarbocyclic spirocyclohexanone and pyrroloiminoquinone systems, and shows the most powerful 
cytotoxic activity among the isolated discorhabdins.  
First,  on  the  basis  of  the  hypothesis  by  Munro  and  co-workers  [56],  we  examined  the 
biosynthetically plausible route from makaluvamine F (48) using our previously developed oxidative 
spirocyclization reaction with PIFA. As a result, the oxidative cyclization of makaluvamine F (48) as 
well as the trimethylsilylated makaluvamine F using PIFA under various conditions yielded a complex 
mixture, probably due to the high reactivity of the iodine(III) reagent toward the sulfide group, the 
aminoiminoquinone skeleton, and the phenolic OH group in makaluvamine F (48) (Scheme 18). 
Scheme 18. Synthetic approach of discorhabdin A from makaluvamine F. 
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Therefore, we altered the synthetic strategy. The new strategy included the pre-construction of the 
spirodienone system using the hypervalent iodine(III) reagent and the final introduction of the sulfur 
group to the cross-linked system. We first examined the shorter path via an amino acid derivative. The 
tritylation of the L-tyrosine methyl ester hydrochloride (73) with TrCl and Et3N followed by mono-
bromination  with  NBS  yielded  74  (two  steps,  65%  yield).  The  coupling  reaction  of  74  with 
pyrroloiminoquinone  25,  which  was  prepared  by  our  previously  developed  PIFA-induced 
pyrroloiminoquinone formation, provided 75 as its CF3CO2H salt (75· TFA). We then examined the 
oxidative spirocyclization reaction of 75· TFA using PIFA. Although the various reaction conditions 
tested,  this  reaction  did  not  give  the  corresponding  spirodienone,  but  yielded  a  complex  mixture; 
probably because generation of the free base of 75 was difficult. This might be because 75· TFA has an 
active methine proton and readily decomposed under basic conditions (even in the presence of Et3N). 
Thus, we modified the synthetic strategy using an alternative route via the amino alcohol as follows: 
reduction of 74 with DIBAH followed by silylation of the resulting alcohol with TBSCl gave the bis-
silylated  compound  76,  and  a  coupling  reaction  with  pyrroloiminoquinone  25  yielded  77.  The 
spirodienone formation of 77 using PIFA effectively proceeded in the presence of MK10 to give a Mar. Drugs 2010, 8                            
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diastereomeric  mixture  of  78  and  78’.  Both  diastereomers  were  readily  separated  by  column 
chromatography on silica gel to give the less polar isomer 78 and the polar isomer 78’ (Scheme 19). 
Scheme 19. The synthesis of spirodienone. 
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The major isomer 78, whose absolute stereochemistry (S configuration) of the spirocenter (C-6) is 
the same as that of natural discorhabdin A (1), was desilylated by BF3· Et2O, and then converted into 
the  N,O-acetal  intermediate  79  by  an  oxidative  fragmentation  reaction  with  C6F5I(OCOCF3)2  and 
MeOH. The p-methoxybenzylthio group was efficiently introduced in the presence of BF3· Et2O to give 
the unstable N,S-acetal A as a diastereomeric mixture. The debenzylation of A, a labile and highly 
functionalized compound, also required the mildest possible reaction conditions. Our initial strategy 
was to perform a mild debenzylation on the p-methoxybenzylsulfonium salt formed by the 1,4-addition 
of a sulfide group to the cyclohexadienone moiety. Accordingly, we treated a diastereomeric mixture 
of A with 30% HBr-AcOH followed by aqueous work up with MeNH2 that produced the N-tosylated 
discorhabdin A (80). Ultimately, we developed an efficient one-pot transformation procedure yielding 
80 from 79. The procedure using p-methoxybenzylthiol in 30% HBr-AcOH (36 h; -78~4 ° C) followed 
by treatment with aqueous MeNH2 mainly gave 80: the enantiomeric excess (ee) of 80 was confirmed 
to be >99% by HPLC analysis using a chiral column (DAICEL CHIRALCEL OD; n-Hex/i-PrOH = 
65/35; 20 ° C). Finally, removal of the tosyl group of 80 with NaOMe in THF gave discorhabdin A (1) 
in the optically pure form for the first time (Scheme 20. The synthetic product as its HCl salt was 
identical  in  all  respects  with  the  natural  discorhabdin  A  including  its  optical  rotation  {synthetic 
discorhabdin A: []D +388 (c = 0.06, MeOH); natural discorhabdin A: []D +400 (c = 0.05, MeOH)} 
and 
1H NMR nOe data.  Mar. Drugs 2010, 8                            
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Scheme 20. The total synthesis of (+)-discorhabdin A. 
N
H
N
Ts
O
Br
N
O TBSO
N
H
O
Br
p-MeOBnS N
H
N
Ts
O
Br
N
O
S
H
N
H
N
Ts
O
Br
N
O
MeO
d) NaOMe
CH2Cl2
N
H
N
H
O
Br
N
O
S
H
a) BF3 Et2O .
b) C6F5I(OCOCF3)2
    NaHCO3, MS3A
    CH3CN-MeOH
    2 steps 70%
c) p-MeOBnSH
    HBr-AcOH
-78~4
 oC
aq. MeNH2
22% THF-MeOH
61%
discorhabdin A (1)
78 79
80
6S
8S
A  
 
Furthermore,  we  also  completed  the  total  synthesis  of  the  unnatural  discorhabdin  A,  (-)-
discorhabdin A, starting from the  D-tyrosine methyl ester by the same route as described for (+)-
discorhabdin A (1) {synthetic product: []D -390 (c = 0.05, MeOH)}. 
5. Semi-Synthesis of Discorhabdins P and U [57] 
In 2006, Copp et al. reported the semi-synthetic preparation of discorhabdins P (81) and U (13) 
from natural discorhabdins C (7) and B (4). In New Zealand waters, Latrunculia sp. sponges are a rich 
source of the discorhabdin alkaloids, with organisms capable of producing either discorhabdins A (1), 
B (4) or C (7) as their major secondary metabolites, typically in isolated yields of 25-35 mg/g dry 
sponge  weight  [58].  The  aim  of  the  Copp  et  al.  study  was  to  investigate  the  methylation  of 
discorhabdin C (7) in an effort to prepare discorhabdin P (81) or related N-methyl analogs for further 
biological testing, and for the first time, to prepare similar analogs of discorhabdin B (4) in an effort to 
expand the structure-activity relationship understanding of this class of compounds. Discorhabdin C 
(7) was reacted with CH3I in dry acetone to yield a single major product, the 13-N-methyl analog 
discorhabdin P (81) in 54% yield (Scheme 21). Discorhabdin B (4) was reacted with CH3I in dry 
acetone  to  yield  two  products,  discorhabdin  U  (13)  and  82.  The  products  of  this  reaction  were 
dependent upon the molar equivalents of CH3I used: with a large excess (10–25 equivalent) yielding 
predominantly discorhabdin U (13), while a two molar equivalent of CH3I yielded the mono-methyl 82. 
The order of the methylation of discorhabdin B (4) preferentially favors the thio group and a large 
excess of CH3I enables the methylation at the N-13 pyrrole position.  Mar. Drugs 2010, 8                            
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Scheme 21. The semi-synthesis of discorhabdin P and U. 
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6. Total Synthesis of Prianosin B [44] 
Although, some 20 years ago, Kobayashi et al. also reported one such family, prianosin B (2), 
which has the 16,17-dehydropyrroloiminoquinone structure, its synthesis has not yet been reported 
[17]. For the synthesis of prianosin B (2), the construction of the 16,17-dehydropyrroloiminoquinone 
structure is an important issue. We have succeeded in the first total synthesis of the sulfur-containing 
discorhabdin, discorhabdin A [40–43]. We postulated that the prianosins and discorhabdins with the 
16,17-dehydropyrroloiminoquinone  moiety  can  be  synthesized  by  dehydrogenation  of  the 
pyrroloiminoquinone of the discorhabdin A (1) or discorhabdin A intermediate (Scheme 22). 
Scheme 22. Synthetic strategy for prianosin B. 
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We  first  examined  the  dehydrogenation  reaction  of  the  simple  spirodienone  (83)  with  various 
oxidants as the model reaction. However, reactions with oxidants, such as DDQ, CAN, MnO2 and 
Pd/C (Yamamura’s conditions) [59], gave poor results (Scheme 23). Mar. Drugs 2010, 8                            
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Scheme 23. Model study using various oxidants. 
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We next tried the use of nucleophiles, because White et al. reported that the dehydrogenation and 
detosylation of the pyrroloiminoquinone system using sodium azide as a nucleophile [60]. From a 
detailed study of nucleophiles, we found that the use of a catalytic amount of NaN3 produced the best 
result.  Since  it  was  revealed  that  the  detosylation  and  dehydrogenation  reaction  of  the 
pyrroloiminoquinone unit with a catalytic amount of NaN3 proceeded in good yield, the total synthesis 
of prianosin B (2) was next studied (Scheme 24). In our own total synthesis of discorhabdin A (1), the 
N,O-acetal intermediate (79) was prepared from the  L-tyrosine methyl ester hydrochloride in eight 
steps. The sulfur cross linkage reaction of the intermediate was carried out using p-MeOBnSH and 
30%  HBr-AcOH  followed  by  aqueous  MeNH2  to  give  the  sulfur-linked  pyrroloiminoquinone 
compound 80. The treatment of 80 with NaN3 in DMF caused detosylation and dehydrogenation to 
produce prianosin B (2) in 48% yield. The spectral data were identical to that reported for the natural 
prianosin B (2) ([]
23
D +362 (c 0.405, CHCl3), lit. []
30
D +360 (c 0.1, CHCl3) [17]). 
Scheme 24. The total synthesis of prianosin B. 
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For determining the reaction mechanism, two studies were carried out. One was the measurement of 
the mass spectrum of the reaction mixture. A suspension of spirodienone 83 and NaN3 in DMF was 
stirred under nitrogen at 70 
oC for 40 min. The mass spectrum of the reaction mixture revealed the ion 
peak of TsN3. The other was the reaction of the N-H spirodienone 85 and TsN3 under basic conditions. 
Thus, NaH and TsN3 were added to a solution of 85 in DMF and the aromatic compound 86 was 
obtained in 41% yield (Scheme 25).  
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Scheme 25. The reaction of N-H spirodienone, TsN3 and NaH. 
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A plausible reaction mechanism for the present dehydrogenation reaction of pyrroloiminoquinone 
using NaN3 is illustrated in Scheme 26. It would involve the nucleophilic attack of N3
- on the tosyl 
residue followed by the addition of metalo enamine to TsN3 to produce the intermediate I [61–63]. 
Dehydrogenation would proceed by the intramolecular elimination via a six-membered transition state 
to produce the intermediate III and isomerization to produce 86 [64–65]. Reproduction of the azide 
anion  during  the  reaction  would  make  possible  the  use  of  the  catalytic  amount  of  NaN3.  The 
reproduction of the azide anion was deduced from the presence of toluenesulfinic acid observed in the 
1H-NMR spectrum (Scheme 26). 
Scheme  26.  A  plausible  mechanism  for  the  dehydrogenation  reaction  of 
pyrroloiminoquinone using NaN3. 
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7. Summary 
In this review, we described the existing studies on the total synthesis of the discorhabdins. Because 
of their prominent potent antitumor activity and unusual ring structure, synthesis of the discorhabdins 
has attracted the interests of many organic chemists. Many synthetic approaches have appeared over 
the  past  decade,  however,  only  few  discorhabdins  have  been  completely  synthesized.  We  have 
accomplished the total syntheses of discorhabdins C, A and prianosin B. Discorhabdin A has the 
strongest  activity  in  vitro,  but  no  activity  in  vivo.  Therefore,  we  are  synthesizing  a  variety  of 
discorhabdin analogs [66]. Although many synthetic studies of the discorhabdin alkaloids have already 
appeared,  biological  studies  including  structure  activity  relationship  or  the  mode  of  action  of  the Mar. Drugs 2010, 8                            
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discorhabdins have not yet significantly occurred [67–71]. In the next stage, it is necessary to study the 
structure activity relationship and the mode of action of the discorhabdins. 
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